Uneven Genetic Robustness of HIV-1 Integrase

被引:18
|
作者
Rihn, Suzannah J. [1 ,2 ]
Hughes, Joseph [3 ]
Wilson, Sam J. [3 ]
Bieniasz, Paul D. [1 ,2 ,4 ]
机构
[1] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, New York, NY 10021 USA
[2] Rockefeller Univ, Lab Retrovirol, New York, NY 10021 USA
[3] Univ Glasgow, MRC, Coll Med Vet & Life Sci, Ctr Virus Res,Inst Infect Immun & Inflammat, Glasgow, Lanark, Scotland
[4] Howard Hughes Med Inst, Aaron Diamond AIDS Res Ctr, New York, NY USA
关键词
IMMUNODEFICIENCY-VIRUS TYPE-1; PROTEIN IN-VITRO; SINGLE-NUCLEOTIDE SUBSTITUTIONS; RETROVIRAL DNA INTEGRATION; X-RAY STRUCTURES; VIRAL REPLICATION; RNA VIRUS; PREINTEGRATION COMPLEXES; CRYSTAL-STRUCTURE; TERMINAL DOMAINS;
D O I
10.1128/JVI.02451-14
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Genetic robustness (tolerance of mutation) may be a naturally selected property in some viruses, because it should enhance adaptability. Robustness should be especially beneficial to viruses like HIV-1 that exhibit high mutation rates and exist in immunologically hostile environments. Surprisingly, however, the HIV-1 capsid protein (CA) exhibits extreme fragility. To determine whether fragility is a general property of HIV-1 proteins, we created a large library of random, single-amino-acid mutants in HIV-1 integrase (IN), covering >40% of amino acid positions. Despite similar degrees of sequence variation in naturally occurring IN and CA sequences, we found that HIV-1 IN was significantly more robust than CA, with random nonsilent IN mutations only half as likely to cause lethal defects. Interestingly, IN and CA were similar in that a subset of mutations with high in vitro fitness were rare in natural populations. IN mutations of this type were more likely to occur in the buried interior of the modeled HIV-1 intasome, suggesting that even very subtle fitness effects suppress variation in natural HIV-1 populations. Lethal mutations, in particular those that perturbed particle production, proteolytic processing, and particle-associated IN levels, were strikingly localized at specific IN subunit interfaces. This observation strongly suggests that binding interactions between particular IN subunits regulate proteolysis during HIV-1 virion morphogenesis. Overall, use of the IN mutant library in conjunction with structural models demonstrates the overall robustness of IN and highlights particular regions of vulnerability that may be targeted in therapeutic interventions. IMPORTANCE The HIV-1 integrase (IN) protein is responsible for the integration of the viral genome into the host cell chromosome. To measure the capacity of IN to maintain function in the face of mutation, and to probe structure/function relationships, we created a library of random single-amino-acid IN mutations that could mimic the types of mutations that naturally occur during HIV-1 infection. Previously, we measured the robustness of HIV-1 capsid in this manner and determined that it is extremely intolerant of mutation. In contrast to CA, HIV-1 IN proved relatively robust, with far fewer mutations causing lethal defects. However, when we subsequently mapped the lethal mutations onto a model of the structure of the multisubunit IN-viral DNA complex, we found the lethal mutations that caused virus morphogenesis defects tended to be highly localized at subunit interfaces. This discovery of vulnerable regions of HIV-1 IN could inform development of novel therapeutics.
引用
收藏
页码:552 / 567
页数:16
相关论文
共 50 条
  • [1] HIV-1 integrase inhibitor
    Lloyd, AW
    [J]. DRUG DISCOVERY TODAY, 1996, 1 (04) : 170 - 170
  • [2] Integrase and integration: biochemical activities of HIV-1 integrase
    Delelis, Olivier
    Carayon, Kevin
    Saib, Ali
    Deprez, Eric
    Mouscadet, Jean-Francois
    [J]. RETROVIROLOGY, 2008, 5 (1)
  • [3] Integrase and integration: biochemical activities of HIV-1 integrase
    Olivier Delelis
    Kevin Carayon
    Ali Saïb
    Eric Deprez
    Jean-François Mouscadet
    [J]. Retrovirology, 5
  • [4] QSAR of HIV-1 integrase inhibitors by genetic function approximation method
    Makhija, MT
    Kulkarni, VM
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2002, 10 (05) : 1483 - 1497
  • [5] Multimodal Functionalities of HIV-1 Integrase
    Engelman, Alan N.
    Kvaratskhelia, Mamuka
    [J]. VIRUSES-BASEL, 2022, 14 (05):
  • [6] Inhibition of HIV-1 integrase by hydroxocobalamin
    Weinberg, JB
    Fyfe, JA
    Sherman, PA
    [J]. BLOOD, 1995, 86 (10) : 2231 - 2231
  • [7] The future of integrase inhibitors of HIV-1
    Malet, Isabelle
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    [J]. CURRENT OPINION IN VIROLOGY, 2012, 2 (05) : 580 - 587
  • [8] The binding properties of HIV-1 integrase
    Voloshchuk, N
    Hawkins, M
    Davenport, L
    [J]. BIOPHYSICAL JOURNAL, 2000, 78 (01) : 300A - 300A
  • [9] The hunt for HIV-1 integrase inhibitors
    Lataillade, Max
    Kozal, Michael J.
    [J]. AIDS PATIENT CARE AND STDS, 2006, 20 (07) : 489 - 501
  • [10] Arylamide inhibitors of HIV-1 integrase
    Zhao, H
    Neamati, N
    Mazumder, A
    Sunder, S
    Pommier, Y
    Burke, TR
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (08) : 1186 - 1194